Gardiner Harris writes in the New York Times:
A series of drug-safety scandals has led many on Capitol Hill to question whether the Food and Drug Administration has failed to strike the right balance between speed and safety. A clear sign of this imbalance, these critics say, is the increasing number of F.D.A. drug-safety officers who say they have been punished or ignored after uncovering dangers of popular medicines.
The problem is not only the FDA rubber-stamping drugs for the market, but also leaving unsafe products on the market after they are found to be dangerous. Isn’t it time we stood up and demanded that our regulators be independent of the companies they are regulating?50